Concepedia

Sarah LeBlanc

SL

Statistics

Publications

7

Citations

1.1K

H-Index

7

Active since

2010

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

McGill University Health Centre

Vanderbilt University

McGill University

Massachusetts Institute of Technology

Sarah LeBlanc is an author at Alnylam Pharmaceuticals (United States) specializing in life sciences, molecular biology, and gene therapy.

Publications per year

2010–2022

7

Publications

7

Basolateral to Central Amygdala Neural Circuits for Appetitive Behaviors

Joshua Kim, Xiangyu Zhang, Shruti Muralidhar et al. · Neuron · 2017 · 495 citations · Full text

, , +14

Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates

Kirk Brown, Jayaprakash K. Nair, Maja M. Janas et al. · Nature Biotechnology · 2022 · 245 citations

, , +16

mRNA-engineered mesenchymal stem cells for targeted delivery of interleukin-10 to sites of inflammation

Oren Levy, Weian Zhao, Luke J. Mortensen et al. · Blood · 2013 · 217 citations · Full text

, , +14

From bench to bedside: Improving the clinical safety of GalNAc–siRNA conjugates using seed-pairing destabilization

Mark K. Schlegel, Maja M. Janas, Yongfeng Jiang et al. · Nucleic Acids Research · 2022 · 90 citations · Full text

, , +17

CEACAM1: a key regulator of vascular permeability

Anne‐Laure Nouvion, Malika Oubaha, Sarah LeBlanc et al. · Journal of Cell Science · 2010 · 61 citations · Full text

, , +17

1–5 of 7